Your browser doesn't support javascript.
loading
Testing for SARS-CoV-2 among cruise ship travelers repatriated to the United States, February to March 2020
Michelle A Waltenburg; Mary A Pomeroy; Laura Hughes; Jeremy A.W. Gold; Oren Mayer; Arnold Vang; Benjamin D Hallowell; Loretta Foster; Kerui Xu; Rita Espinoza; Kristina Hsieh; Emily G Pieracci; Gabriella Wuyke; Juliana Da Silva; R. Paul McClung; Jonathan Steinberg; Matthew Westercamp; Snigdha Vallabhaneni; Jessica Li; Amy L. Valderrama; George R. Grimes; R. Reid Harvey; Randall J. Nett; Kindra Stokes; Stephen Lindstrom; Allison D. Miller; Eric P. Griggs; Jennifer L. Milucky; Adam Bjork; Valerie Albrecht; Wendi L. Kuhnert; Carolyn V. Gould; Nancy W. Knight; Noele P. Nelson; Margaret A. Honein; Casey Barton Behravesh; - CDC COVID-19 Investigation Team; Christine L. Dubray; Grace E. Marx.
Affiliation
  • Michelle A Waltenburg; Centers for Disease Control and Prevention
  • Mary A Pomeroy; Centers for Disease Control and Prevention
  • Laura Hughes; Centers for Disease Control and Prevention
  • Jeremy A.W. Gold; Centers for Disease Control and Prevention
  • Oren Mayer; Centers for Disease Control and Prevention
  • Arnold Vang; Centers for Disease Control and Prevention
  • Benjamin D Hallowell; Centers for Disease Control and Prevention
  • Loretta Foster; Centers for Disease Control and Prevention
  • Kerui Xu; Centers for Disease Control and Prevention
  • Rita Espinoza; San Antonio Metropolitan Health District
  • Kristina Hsieh; California Department of Public Health
  • Emily G Pieracci; Centers for Disease Control and Prevention
  • Gabriella Wuyke; Centers for Disease Control and Prevention
  • Juliana Da Silva; Centers for Disease Control and Prevention
  • R. Paul McClung; Centers for Disease Control and Prevention
  • Jonathan Steinberg; Centers for Disease Control and Prevention,
  • Matthew Westercamp; Centers for Disease Control and Prevention,
  • Snigdha Vallabhaneni; Centers for Disease Control and Prevention
  • Jessica Li; Centers for Disease Control and Prevention
  • Amy L. Valderrama; Centers for Disease Control and Prevention
  • George R. Grimes; Centers for Disease Control and Prevention
  • R. Reid Harvey; Centers for Disease Control and Prevention
  • Randall J. Nett; Centers for Disease Control and Prevention
  • Kindra Stokes; Centers for Disease Control and Prevention
  • Stephen Lindstrom; Centers for Disease Control and Prevention
  • Allison D. Miller; Centers for Disease Control and Prevention
  • Eric P. Griggs; Centers for Disease Control and Prevention
  • Jennifer L. Milucky; Centers for Disease Control and Prevention
  • Adam Bjork; Centers for Disease Control and Prevention
  • Valerie Albrecht; Centers for Disease Control and Prevention
  • Wendi L. Kuhnert; Centers for Disease Control and Prevention
  • Carolyn V. Gould; Centers for Disease Control and Prevention
  • Nancy W. Knight; Centers for Disease Control and Prevention
  • Noele P. Nelson; Centers for Disease Control and Prevention
  • Margaret A. Honein; Centers for Disease Control and Prevention
  • Casey Barton Behravesh; Centers for Disease Control and Prevention
  • - CDC COVID-19 Investigation Team;
  • Christine L. Dubray; Centers for Disease Control and Prevention
  • Grace E. Marx; Centers for Disease Control and Prevention
Preprint in English | medRxiv | ID: ppmedrxiv-21258318
ABSTRACT
BackgroundIn early 2020, an outbreak of coronavirus disease 2019 occurred among passengers and crew of the Diamond Princess cruise ship. During February 16-17, some US citizens, residents, and their partners voluntarily repatriated to the US from Japan. MethodsWe conducted a retrospective, longitudinal evaluation of repatriated travelers where the outcome of interest was a positive test for SARS-CoV-2. Travelers who tested positive for SARS-CoV-2 were isolated in hospitals or at home under county isolation orders and underwent serial testing by real-time reverse transcription polymerase chain reaction (RT-PCR) approximately every other day, as contemporaneous US guidance required two consecutive negative tests collected [≥]24 hours apart and symptom improvement before release from isolation. ResultsAmong quarantined repatriated travelers, 14% tested positive for SARS-CoV-2. One-fifth of infected travelers initially tested negative but were identified on subsequent testing. All infected travelers remained asymptomatic or developed mild symptoms during isolation. Many travelers remained in prolonged isolation because of persistent viral detection based on contemporaneous policies. ConclusionOur findings support testing within 3-5 days after possible SARS-CoV-2 exposure to comprehensively identify infections and mitigate transmission and lend support to symptom- and time-based isolation recommendations, rather than test-based criteria.
License
cc_no
Full text: Available Collection: Preprints Database: medRxiv Type of study: Experimental_studies / Observational study / Prognostic study Language: English Year: 2021 Document type: Preprint
Full text: Available Collection: Preprints Database: medRxiv Type of study: Experimental_studies / Observational study / Prognostic study Language: English Year: 2021 Document type: Preprint
...